Pulmonology (Lung Disease)
Research
Pulmonologists at NewYork-Presbyterian Morgan Stanley Children's Hospital are leaders in research for furthering the understanding of respiratory disorders and evaluating new treatments.
NewYork-Presbyterian Morgan Stanley Children's Hospital is one of 10 National Institutes of Health-funded research centers in the United States. Under the leadership of Meyer Kattan, MD, Director, Division of Pulmonology, the program is aimed at developing and carrying out a long-range scientific plan to reduce asthma severity and prevent asthma among inner city children, and to identify the mechanisms involved in the immunopathogenesis of asthma in these populations. Some 6.5 million children under 18 currently have asthma in the U.S., and low-income populations, racial and ethnic minorities are disproportionately affected.
Led by David Evans, PhD, Beverly J. Sheares, MD, and Robert B. Mellins, MD, the Division Pulmonology has a long history in the development of asthma education programs for schools, families and health care providers.
NewYork-Presbyterian Morgan Stanley Children's Hospital is a member of the Cystic Fibrosis Foundation Therapeutic Development Network, a nationwide network of nearly 80 cystic fibrosis clincal research centers. Under the oversight of Lynne M. Quittell, MD, our researchers conduct clinical trials to evaluate the safety and effectiveness of new cystic fibrosis therapies.
The Division of Pulmonology is involved in basic research projects on:
- lung development;
- assessing numerous populations and how their disorders affect lung function and visa versa;
- evaluating transmission of allergic disorders;
- macrophage (a type of white blood that ingests foreign material) function interactions.
Pulmonary clinical research includes:
- evaluating health education for adolescents in New York City high schools (a five-year National Heart, Lung and Blood Institute grant)
- antibiotics in patients with cystic fibrosis
- how other disorders affect lung function
- developing a coalition approach to controlling asthma in Northern Manhattan
- evaluating the approach to the inpatient with asthma, and ensuring optimal care for those children
- optimizing care of high school students with asthma
Pediatric allergy and pulmonary specialists at NewYork-Presbyterian Morgan Stanley Children's Hospital are collaborating in research protocols including projects on:
- primary instead of emergency care for asthma;
- developing asthma regulation by families and providers;
- enhancing family self-regulation of asthma in minorities.
Pulmonologists at NewYork-Presbyterian Morgan Stanley Children's Hospital are also participating in a nationwide observational research program - the Epidemiological Study of Cystic Fibrosis (ESCF) - designed to gather information about the care of patients with cystic fibrosis.
The Division of Pulmonology is also involved with benchmark laboratory research funded by the Cystic Fibrosis Foundation. The research is looking at the genetic modification of those immune system cells that protect against pulmonary infections related to cystic fibrosis. The goal is the development of a genetic vaccine.
Contact
- Pediatric Pulmonology
-
Directions
(212) 305-5122
